切换至 "中华医学电子期刊资源库"

中华腔镜泌尿外科杂志(电子版) ›› 2017, Vol. 11 ›› Issue (02) : 101 -104. doi: 10.3877/cma.j.issn.1674-3253.2017.02.006

所属专题: 文献

临床研究

经尿道前列腺电切术治疗合并冠脉支架的前列腺增生患者的临床经验
赵佳晖1,(), 姜永光1, 侯铸1, 彭涛1, 王永兴1, 罗勇1, 李明川1   
  1. 1. 100029 北京,首都医科大学附属北京安贞医院泌尿外科
  • 收稿日期:2016-05-31 出版日期:2017-04-01
  • 通信作者: 赵佳晖
  • 基金资助:
    北京市卫生系统高层次卫生技术人才学科带头人培养基金(2013-2-003)

Clinical experiences of summary of transurethral resection of prostate for begign prostatic hyperplasia with coronary stent

Jiahui Zhao1,(), Yongguang Jiang1, Zhu Hou1, tao Peng1, Yongxing Wang1, Yong Luo1, Mingchuan Li1   

  1. 1. Department of Urology, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China
  • Received:2016-05-31 Published:2017-04-01
  • Corresponding author: Jiahui Zhao
  • About author:
    Correspondence to: Zhao Jiahui, Email:
引用本文:

赵佳晖, 姜永光, 侯铸, 彭涛, 王永兴, 罗勇, 李明川. 经尿道前列腺电切术治疗合并冠脉支架的前列腺增生患者的临床经验[J]. 中华腔镜泌尿外科杂志(电子版), 2017, 11(02): 101-104.

Jiahui Zhao, Yongguang Jiang, Zhu Hou, tao Peng, Yongxing Wang, Yong Luo, Mingchuan Li. Clinical experiences of summary of transurethral resection of prostate for begign prostatic hyperplasia with coronary stent[J]. Chinese Journal of Endourology(Electronic Edition), 2017, 11(02): 101-104.

目的

总结既往行冠脉支架植入的前列腺增生患者行经尿道前列腺电切术(TURP)手术的临床资料和治疗经验。

方法

回顾性分析首都医科大学附属北京安贞医院2010至2015年间合并冠心病既往行冠状动脉支架植入的前列腺增生患者56例,年龄57~86岁,平均72岁。所有患者经充分术前准备,评估手术麻醉等风险,调整血压、改善心功能、停用抗凝药物,行TURP手术。

结果

所有患者均安全度过围手术期,手术均获成功,未发生心脑血管意外及严重并发症,无死亡病例。国际前列腺症状评分(IPSS)由术前(26±5)分降至术后(12±5)分,生活质量评分(QOL)由术前(5.1±0.8)分降至术后(1.9±1.1)分,差异具有统计学意义(P<0.01)。

结论

对于合并冠状动脉支架的前列腺增生患者,进行充分的术前准备及围手术期治疗,TURP手术是一个安全有效的手术治疗方法。

Objective

To summarize the experiences of transurethral resection of prostate(TURP) in the treatment of prostatic hyperplasia patients with coronary stent.

Methods

The clinical data of 56 BPH patients with coronary stent underwent TURP in our department between 2010 and 2015 were reviewed, aging from 57-86 years and 72 years in average. All patients were treated with TURP operation with fully perioperative preparation including assessment of the risk of surgical anesthesia, blood pressure, cardiac function improvement and suspending the anticoagulation.

Results

All of the operations were performed successfully without severe complications during the perioperative period. No cardiovascular and cerebrovascular complications and death occurred. The international prostate symptom scores (IPSS) reduced from (26±5) to (12±5), and quality of life scores (QOL) reduced from (5.1±0.8) to (1.9±1.1) postoperatively.

Conclusion

With fully preoperative preparation, TURP is safe and effective for patients with BPH and coronary sent.

[1]
Gyomber D, Lawrentschuk N, Ranson DL, et al. An analysis of deaths related to urological surgery, reviewed by the State Coroner: a case for cardiac vigilance before transurethral prostatectomy[J]. BJU Int, 2006, 97(4):758-761.
[2]
Ong AT, Hoye A, Aoki J, et al. Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation[J]. J Am Coll Cardiol, 2005, 45(6):947-953.
[3]
de la Torre-Hernández JM, Alfonso F, Hernández F, et al. Drug-eluting stent thrombosis: results from the multicenter Spanish registry ESTROFA (Estudio ESpañol sobre TROmbosis de stents FArmacoactivos)[J]. J Am Coll Cardiol, 2008, 51(10):986-990.
[4]
Murray J, Saxena S, Millett C, et al. Reductions in risk factors for secondary prevention of coronary heart disease by ethnic group in south-west London: 10-year longitudinal study (1998-2007)[J]. Fam Pract, 2010, 27(4):430-438.
[5]
Burger W, Chemnitius JM, Kneissl GD, et al. Low-dose aspirin for secondary cardiovascular prevention cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation - review and meta-analysis[J]. J Intern Med, 2005, 257(5):399-414.
[6]
Biondi-Zoccai GG, Lotrionte M, Agostoni P, et al. A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease[J]. Eur Heart J, 2006, 27(22):2667-2674.
[7]
Donat R, Wilson I, Raza A, et al. A multicentre prospective, randomised, doubleblind placebo-controlled trial of aspirin during transurethral resection of the prostate (TURP)[J]. J Urol, 2003, 169(2):466-467.
[8]
Taylor K, Filgate R, Guo DY, et al. A retrospective study to assess the morbidity associated with transurethral prostatectomy in patients on antiplatelet or anticoagulant drugs[J]. BJU Int, 2011, 108(2):45-50.
[9]
Wenders M, Wenzel O, Nitzke T, et al. Perioperative platelet inhibition in transurethral interventions: TURP/TURB[J]. Int Braz J Urol, 2012, 38(5):606-610.
[10]
Nielsen JD, Holm-Nielsen A, Jespersen J, et al. The effect of low-dose acetylsalicylic acid on bleeding after transurethral prostatectomy--a prospective, randomized, double-blind, placebo-controlled study[J]. Scand J Urol Nephrol, 2000, 34(3):194-198.
[11]
Enver MK, Hoh I, Chinegwundoh FI. The management of aspirin in transurethral prostatectomy: current practice in the UK[J]. Ann R Coll Surg Engl, 2006, 88(3):280-283.
[12]
杨毅,陈荣,吴德锋,等.经尿道前列腺电切术术前停服阿司匹林的时机选择[J].浙江实用医学, 2015, 20(3):201-203.
[13]
袁渊,姚启盛,王晓康,等.高龄前列腺增生患者合并心血管疾病的围手术期处理[J].中华腔镜泌尿外科杂志:电子版, 2013, 7(1):25-28.
[14]
Rubino AS, Della Corte A, Giordano R, et al. Impact of preoperative antiplatelet therapy on in-hospital outcomes after coronary artery bypass grafting[J]. Eur J Cardiothorac Surg, 2014, 46(2):335.
[15]
Ong WL, Koh TL, Fletcher J, et al. Perioperative management of antiplatelets and anticoagulants among patients undergoing elective transurethral resection of the Prostate--A single institution experience[J]. J Endourol, 2015, 29(11):1321-1327.
[1] 熊风, 林辉煌, 陈晓波. 铥激光在泌尿外科中的临床应用及研究进展[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(05): 533-536.
[2] 韩广玮, 申雪晴, 吴涵潇, 曹炎武, 唐黎明. 前列腺增生并轻度尿道狭窄行去外鞘半导体激光汽化剜除与等离子电切的比较[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(05): 490-494.
[3] 李腾成, 谭益元, 黄群雄, 吴杰英, 肖恒军, 胡成, 李茂胤, 高新, 狄金明. 机器人腹腔镜后入路完全筋膜内根治性前列腺切除术治疗早期前列腺癌[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(05): 452-456.
[4] 李全喜, 唐辉军, 唐友杰, 杨飞. DISCO成像技术在前列腺增生与前列腺癌鉴别诊断中的应用价值[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(04): 332-335.
[5] 方昌华, 杜霖, 陈鑫楠, 王昊, 王文帝, 张成伟, 秦海翔, 邱雪峰, 庄君龙, 徐林峰, 郭宏骞, 张古田. 以累积和分析法研究保留耻骨后间隙机器人辅助根治性前列腺切除术的学习曲线[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(04): 319-325.
[6] 单兴利, 王栋, 邢念增, 肖泽均, 李亚健. 68Ga-PSMA-PET/CT对前列腺癌盆腔淋巴结转移诊断价值的研究[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(03): 214-218.
[7] 谢秋波, 周宇, 宋健, 涂忠, 李想, 汪仁昊, 伍依依, 潘铁军. 全息影像在机器人辅助前列腺癌根治术中保留膀胱颈的应用[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(03): 209-213.
[8] 赖良海, 赵伟, 肖云新, 杨伟明, 陈光耀. 1 470 nm激光"平均三分法"剜除术与等离子剜除术治疗前列腺增生的比较[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(03): 252-256.
[9] 李国峰, 李显文, 周祥福, 何昊麟, 杜红兵, 宾开云. 单极滚珠电极与等离子行经尿道前列腺剜除术的比较[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(03): 247-251.
[10] 游猛, 顾志文, 宋生生, 张贺庆, 詹河涓. 等离子电切术与钬激光剜除术治疗体积>80 ml前列腺增生的比较[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(01): 44-49.
[11] 邹志辉, 张礼刚, 胡永涛, 牛迪, 陈佳, 葛秦涛, 尹水平, 杨诚, 施浩强, 邰胜, 周骏, 郝宗耀, 梁朝朝. 无线智能高清内镜在经尿道双极等离子解剖性前列腺剜除术中的应用初探[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(01): 39-43.
[12] 顾志波, 苏倩, 陈建刚, 陆明. 低功率钬激光与等离子剜除治疗中等体积前列腺增生的比较[J]. 中华腔镜泌尿外科杂志(电子版), 2022, 16(06): 496-500.
[13] 邹志辉, 张礼刚, 梁朝朝. 电外科和激光平台等技术在前列腺增生日间手术中的应用[J]. 中华腔镜泌尿外科杂志(电子版), 2022, 16(06): 489-495.
[14] 郑军, 许新, 江爽, 俞继卫. 经腹腹膜前疝修补术治疗前列腺根治性切除术后并发腹股沟疝疗效分析[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(05): 557-560.
[15] 张宁, 张梦菲, 邱建新, 高闫尧, 陈育, 高靖榆. 腹腔镜下经尿道等离子电切术联合疝环充填式无张力疝修补术治疗腹股沟斜疝合并前列腺良性增生[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(04): 441-444.
阅读次数
全文


摘要